Isoform Specific Histone Deacetylase Inhibitor Treatment in a Swine Model of Polytrauma and Sepsis

异构体特异性组蛋白脱乙酰酶抑制剂治疗多发伤和脓毒症猪模型

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Traumatic injuries are the leading cause of death in young Americans. In civilian and military trauma, hemorrhage and traumatic brain injuries (TBI) account for the majority of these deaths. Current treatment is focused on hemorrhage control, blood product resuscitation and support of physiologic parameters. No therapy exists to specifically prevent cellular dysfunction that occurs with shock or traumatic injuries. We have shown that in clinically realistic models of trauma, hemorrhagic shock and TBI, treatment with nonselective histone deacetylase (HDAC) inhibitors improves survival and cognitive function. However, the doses needed for this effect have been very high, raising concern for toxicity. There are 18 known isoforms of HDAC, and we believe that being able to develop a more targeted therapy to inhibit specific isoforms of HDAC would achieve the desired therapeutic effect while decreasing concern for toxicity and adverse reactions. This proposal is a continuation of work done on NIH grant R01GM84127. As part of this grant, we have tested various isoform specific HDAC inhibitors in cell line and rodent models of hemorrhage, trauma and septic shock. Work from cell culture data and small animal models will be used to select the appropriate isoform specific HDAC inhibitors to test in a clinically realistic swine model of hemorrhagic shock, polytrauma including TBI and intra- abdominal sepsis. Using this model, we will be able to compare long term survival and cognitive outcomes after treatment with conventional resuscitation, nonselective HDAC inhibitor and isoform specific HDAC inhibition. Additionally, tissue from swine will be used to elucidate underlying mechanisms that contribute to cell death and dysfunction during trauma, and how HDAC inhibition promotes a “pro-survival” phenotype at the genomic and proteomic level.
项目摘要/摘要 创伤性伤害是年轻美国人死亡的主要原因。在平民和军事中 创伤,出血和创伤性脑损伤(TBI)是这些死亡的大多数。 当前治疗的重点是出血控制,血液产物复苏和支持 生理参数。没有治疗可以专门防止发生的细胞功能障碍 受到冲击或创伤性伤害。我们已经表明,在临床现实的创伤模型中 出血性休克和TBI,用非选择性组蛋白脱乙酰基酶(HDAC)抑制剂处理 提高生存和认知功能。但是,这种效果所需的剂量是 很高,引起人们对毒性的关注。 HDAC有18种已知的同工型,我们相信 能够开发更有针对性的治疗以抑制HDAC的特定同工型 达到所需的治疗效果,同时减少对毒性和不利的关注 反应。该提案是NIH授予R01GM84127上完成的工作的延续。作为 这笔赠款,我们已经测试了细胞系和啮齿动物中的各种同工型特异性HDAC抑制剂 出血,创伤和败血性休克的模型。细胞培养数据和小动物的工作 模型将用于选择适当的同工型特异性HDAC抑制剂以在A中测试 出血性休克的临床现实猪模型,包括TBI和内部的多发性猪 腹部败血症。使用此模型,我们将能够比较长期生存和认知 常规复苏,非选择性HDAC抑制剂和 同工型特异性HDAC抑制。另外,将使用猪的组织来阐明 在创伤期间导致细胞死亡和功能障碍的基本机制,以及如何 HDAC抑制在基因组和蛋白质组学水平上促进了“促生存”表型。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Validation of intraosseous delivery of valproic acid in a swine model of polytrauma.
  • DOI:
    10.1136/tsaco-2021-000683
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Biesterveld BE;O'Connell R;Kemp MT;Wakam GK;Williams AM;Pai MP;Alam HB
  • 通讯作者:
    Alam HB
Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation.
在长期损害控制复苏的猪模型中,丙戊酸可提高存活率并降低复苏要求。
  • DOI:
    10.1097/ta.0000000000002281
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Williams,AaronM;Bhatti,UmarF;Biesterveld,BenE;Graham,NathanJ;Chtraklin,Kiril;Zhou,Jing;Dennahy,IsabelS;Kathawate,RanganathG;Vercruysse,ClaireA;Russo,RachelM;Li,Yongqing;Alam,HasanB
  • 通讯作者:
    Alam,HasanB
Valproic Acid Protects Against Acute Kidney Injury in Hemorrhage and Trauma.
  • DOI:
    10.1016/j.jss.2021.04.014
  • 发表时间:
    2021-10
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Biesterveld BE;Siddiqui AZ;O'Connell RL;Remmer H;Williams AM;Shamshad A;Smith WM;Kemp MT;Wakam GK;Alam HB
  • 通讯作者:
    Alam HB
Valproic acid treatment rescues injured tissues after traumatic brain injury.
  • DOI:
    10.1097/ta.0000000000002918
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Biesterveld BE;Pumiglia L;Iancu A;Shamshad AA;Remmer HA;Siddiqui AZ;O'Connell RL;Wakam GK;Kemp MT;Williams AM;Pai MP;Alam HB
  • 通讯作者:
    Alam HB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ben Edwin Biesterveld其他文献

Ben Edwin Biesterveld的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis
HIV 相关结核病治疗毒性、失败和复发的预测因素
  • 批准号:
    9199006
  • 财政年份:
    2016
  • 资助金额:
    $ 6.1万
  • 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
  • 批准号:
    8913968
  • 财政年份:
    2013
  • 资助金额:
    $ 6.1万
  • 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
  • 批准号:
    8716885
  • 财政年份:
    2013
  • 资助金额:
    $ 6.1万
  • 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
  • 批准号:
    8735149
  • 财政年份:
    2013
  • 资助金额:
    $ 6.1万
  • 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
  • 批准号:
    8425616
  • 财政年份:
    2012
  • 资助金额:
    $ 6.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了